I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Post‐progression survival after atezolizumab plus carboplat..:
Ken Masubuchi
;
Hisao Imai
;
Satoshi Wasamoto
...
https://doi.org/10.1111/1759-7714.14621. , 2022
Link:
https://doi.org/10.1111/1759-7714.14621
RT Journal T1
Post‐progression survival after atezolizumab plus carboplatin and etoposide as first‐line chemotherapy in small cell lung cancer has a significant impact on overall survival
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:64e6b20ba7e5445abb1fbb3bc51921e4&Exemplar=1&LAN=DE A1 Ken Masubuchi A1 Hisao Imai A1 Satoshi Wasamoto A1 Takeshi Tsuda A1 Hiroyuki Minemura A1 Yoshiaki Nagai A1 Yutaka Yamada A1 Takayuki Kishikawa A1 Yukihiro Umeda A1 Ayako Shiono A1 Hiroki Takechi A1 Jun Shiihara A1 Kyoichi Kaira A1 Kenya Kanazawa A1 Hirokazu Taniguchi A1 Takayuki Kaburagi A1 Hiroshi Kagamu A1 Koichi Minato PB Wiley YR 2022 K1 atezolizumab K1 carboplatin K1 etoposide K1 overall survival K1 post‐progression survival K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://doi.org/10.1111/1759-7714.14621 LK http://dx.doi.org/https://doi.org/10.1111/1759-7714.14621 DO https://doi.org/10.1111/1759-7714.14621 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)